Deprescribing Potentially Inappropriate Medications in the Emergency Department for Persons Living With Dementia - Trial NCT06273917
Access comprehensive clinical trial information for NCT06273917 through Pure Global AI's free database. This phase not specified trial is sponsored by National Institute on Aging (NIA) and is currently Not yet recruiting. The study focuses on Dementia. Target enrollment is 290 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
National Institute on Aging (NIA)
Timeline & Enrollment
N/A
Mar 01, 2024
Jan 01, 2025
Primary Outcome
Pharmacist communication of deprescribing recommendation
Summary
Aim 1: To demonstrate the feasibility by determining proportion of completed medication
 reconciliation, Central Nervous System active Potentially Inappropriate Medication (CNS PIM)
 use among patients with Alzheimer's Disease and Related Dementias (ADRD) and Mild Cognitive
 Impairment (MCI) in the emergency department (ED), and communication between ED clinical
 pharmacists and outpatient prescribers.
 
 Aim 2: To demonstrate the feasibility of collecting the primary and secondary outcomes for a
 subsequent study. The future primary outcome will be reduction in CNS PIMs 90 days after an
 ED visit. Secondary outcomes will include outpatient follow-up, repeat ED visits, and
 hospitalizations during the 90 days following an ED visit.
 
 Aim 3: To demonstrate the acceptability of the PRIDE intervention to outpatient clinicians
 using the Acceptability of Intervention Measure and qualitative analysis of responses.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06273917
Non-Device Trial